Showing results (401-410 of 472) with videos related to
Sort By:
Pageof 48
The Journal of Urology|August 22, 2025
Incidence of local treatment and metastasis during active surveillance for patients with a small renal mass in a national multicenter prospective cohortLuke T Lavallée, Antonio Finelli, Simon Tanguay, et al.Clinical Genitourinary Cancer|February 4, 2022
Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma PatientsMyuran Thana, Naveen S Basappa, Sunita Ghosh, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 19, 2017
First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experienceAly-Khan A Lalani, Haocheng Li, Daniel Y C Heng, et al.Urologic Oncology|May 18, 2023
Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world populationBraden Millan, Rodney H Breau, Ranjeeta Mallick, et al.Advances in Radiation Oncology|July 11, 2022
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information SystemEric K Nguyen, Aly Khan A Lalani, Sunita Ghosh, et al.JNCI Cancer Spectrum|December 20, 2021
Real-World Use of Androgen-Deprivation Therapy: Intensification Among Older Canadian Men With de Novo Metastatic Prostate CancerChristopher J D Wallis, Shawn Malone, Ilias Cagiannos, et al.Clinical Genitourinary Cancer|June 23, 2021
Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information SystemIgal Kushnir, Naveen S Basappa, Sunita Ghosh, et al.Current Oncology (Toronto, Ont.)|March 27, 2026
Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis)Erica Arenovich, Rodney Breau, Ricardo Rendon, et al.European Urology|April 6, 2024
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR StudyRobert J Motzer, Toni K Choueiri, Thomas Hutson, et al.Cancers|July 2, 2021
Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in CanadaChristopher J D Wallis, Bobby Shayegan, Scott C Morgan, et al.Pageof 48